These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2786343)
1. Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine. Linet LS Am J Psychiatry; 1989 Jun; 146(6):803-4. PubMed ID: 2786343 [No Abstract] [Full Text] [Related]
2. Augmenting fluoxetine with dextroamphetamine to treat refractory depression. Gupta S; Ghaly N; Dewan M Hosp Community Psychiatry; 1992 Mar; 43(3):281-3. PubMed ID: 1555827 [No Abstract] [Full Text] [Related]
3. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness. Rabkin JG; Rabkin R; Wagner G J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270 [TBL] [Abstract][Full Text] [Related]
4. Possible synergism between fluoxetine and lithium in refractory depression. Pope HG; McElroy SL; Nixon RA Am J Psychiatry; 1988 Oct; 145(10):1292-4. PubMed ID: 3262313 [TBL] [Abstract][Full Text] [Related]
5. Fluoxetine-nortriptyline therapy of treatment-resistant major depression in a geriatric patient. Rothschild BS J Geriatr Psychiatry Neurol; 1994; 7(3):137-8. PubMed ID: 7916935 [No Abstract] [Full Text] [Related]
7. Fluoxetine for depression. Med Lett Drugs Ther; 1988 Apr; 30(764):45-7. PubMed ID: 3258399 [No Abstract] [Full Text] [Related]
8. The effect of fluoxetine in depression associated with multiple sclerosis. Shafey H Can J Psychiatry; 1992 Mar; 37(2):147-8. PubMed ID: 1562960 [No Abstract] [Full Text] [Related]
9. Amphetamine and tranylcypromine in treatment-resistant depression. Sovner R Biol Psychiatry; 1990 Dec; 28(11):1011-2. PubMed ID: 2275949 [No Abstract] [Full Text] [Related]
10. Fluoxetine treatment of trichotillomania and depression in a prepubertal child. Sheikha SH; Wagner KD; Wagner RF Cutis; 1993 Jan; 51(1):50-2. PubMed ID: 8419112 [TBL] [Abstract][Full Text] [Related]
11. The use of d-amphetamine in medically ill depressed patients. Kaufmann MW; Murray GB J Clin Psychiatry; 1982 Nov; 43(11):463-4. PubMed ID: 7174624 [TBL] [Abstract][Full Text] [Related]
15. The evidence for 20mg a day of fluoxetine as the optimal dose in the treatment of depression. Altamura AC; Montgomery SA; Wernicke JF Br J Psychiatry Suppl; 1988 Sep; (3):109-12. PubMed ID: 3074862 [No Abstract] [Full Text] [Related]
16. What constitutes an adequate antidepressant trial for fluoxetine? Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998 [TBL] [Abstract][Full Text] [Related]
17. Treatment of recurrent unipolar depressions: psychological and biological aspects. Dufour H Bibl Psychiatr; 1994; (165):79-85. PubMed ID: 7993365 [No Abstract] [Full Text] [Related]
18. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression. Fontaine R; Ontiveros A; Elie R; Vézina M Biol Psychiatry; 1991 May; 29(9):946-8. PubMed ID: 1904782 [No Abstract] [Full Text] [Related]
19. Triiodothyronine potentiation of fluoxetine in depressed patients. Joffe RT Can J Psychiatry; 1992 Feb; 37(1):48-50. PubMed ID: 1551045 [TBL] [Abstract][Full Text] [Related]
20. Fluoxetine and desipramine: a strategy for augmenting anti-depressant response. Eisen A Pharmacopsychiatry; 1989 Nov; 22(6):272-3. PubMed ID: 2616636 [No Abstract] [Full Text] [Related] [Next] [New Search]